Philips showcases latest patient-driven sleep and respiratory solutions

Innovations on show at European Respiratory Society International Congress 2015

Philips Respironics, a division of Royal Philips, showcased its latest portfolio of sleep-disordered breathing and respiratory solutions at the recent European Respiratory Society International Congress in Amsterdam.

Clinicians were able to experience the latest Philips sleep-disordered breathing solutions and new options for COPD management that connect and support the patient, clinician and caregiver to improve patient care and help patients to live active lives.

Philips’ sleep therapy portfolio connects the provider and the patient at the most-important points in the care continuum, from diagnosis to compliance and ongoing use and resupply.

The following new sleep-disordered breathing solutions were on display:

• Dream Family: The new, fully-integrated, patient-centric sleep therapy solution from Philips features a connected positive airway pressure (PAP) therapy device, complementary mask line, and engagement tools to improve care for obstructive sleep apnea (OSA) patients. The Dream Family integrated solution includes the DreamStation PAP device, DreamWear mask, and DreamMapper personalised coaching tool. The Dream Family, which will become available to patients and care teams in select countries after October, is designed to engage patients in natural, comfortable and effective sleep therapy while seamlessly connecting them to their care teams for optimal therapy management
• Amara View: A minimal contact, full-face mask, the under-the-nose design of Amara View prevents red marks, discomfort and irritation on the bridge of the nose. It also offers the widest field of vision of leading full-face masks

“As a leader in sleep apnea treatment innovation, Philips continuously aims to expand its CPAP mask offerings with an emphasis on patient comfort,” said Mark D’Angelo, sleep business leader at Philips.

“By addressing patient concerns, like limited mobility and mask-related irritation, we can provide patients with more personalised options to help them adapt to and stick with their OSA treatment, and get the sleep they deserve.

“Philips Respironics is committed to providing one unified approach to COPD care – co-ordinated, consistent, uninterrupted and centered around the patient and the home. Our goal is to help reduce hospitalisations, improve patient care, maximise clinician resources and support patients in living more-active, fulfilling lives.

Respiratory solutions on display at the show included:

• SimplyGo Mini: With an attractive and sleek design and a comfortable carrying case, SimplyGo Mini is a proven solution for patients who struggle with respiratory disorders to continue living full, active lives. The smallest and lightest portable oxygen concentrator (POC) in the Philips portfolio, SimplyGo Mini delivers nearly 20% more oxygen output than any POC weighing five pounds or less
• VitaBreath: VitaBreath is a small, lightweight therapy support device for patients who experience dyspnea related to their COPD. The portable positive airway pressure (PAP) device provides relief within two minutes and can reduce breathlessness recovery time by up to 40%

Companies

• Philips